Cell-cell adhesion in the normal ovary and ovarian tumors of epithelial origin; an exception to the rule

Molecular and Cellular Endocrinology

Volumn 202, Issue 1-2, 2003, Pages 89-96

  Sundfeldt, Karin ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cadherin; Catenin; Cystic fluid; Ovarian neoplasm; Ovarian surface epithelium

Indexed keywords

CADHERIN; CATENIN;

ADENOMA; ANATOMY; CANCER GROWTH; CANCER INVASION; CANCER LOCALIZATION; CARCINOGENESIS; CELL ADHESION; CELL CONTACT; CELL JUNCTION; CONFERENCE PAPER; CYST; EMBRYOLOGY; EPITHELIUM; EPITHELIUM CELL; EXTRACELLULAR MATRIX; GAP JUNCTION; HISTOPATHOLOGY; HUMAN; MESOTHELIUM CELL; OVARY; OVARY ADENOCARCINOMA; OVARY CANCER; OVARY CARCINOMA; OVARY TUMOR; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SOLID TUMOR; STROMA; TIGHT JUNCTION; TUMOR DIFFERENTIATION;

EID: 0038627534     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(03)00068-6     Document Type: Conference Paper

References (88)

1. Adami H.O., Hsieh C.C., Lambe M., Trichopoulos D., Leon D., Persson I., Ekbom A., Janson P.-O. Parity, age at first childbirth and risk of ovarian cancer. Lancet. 344:1994;1250-1254.
2. Auersperg N., Maines-Bandiera S.L., Dyck H.G., Kruk P.A. Characterisation of cultured human ovarian surface epithelial cells: phenotypic plasticity and premalignant changes. Lab. Invest. 71:1994;510-518.
3. Auersperg N., Maines-Bandiera S.L., Dyck H.G. Phenotypic plasticity of ovarian surface epithelium: possible implications for ovarian carcinogenesis. Sharp F., Blackett T., Leake R., Berek J. Ovarian Cancer 4. 1996;3-17 Chapman and Hall, London.
4. Behrens J., Von Kries P.J., Kuhl M., Bruhn L., Wedlich D., Grosschedl R., Birchmeier W. Functional interaction of beta-catenin with the transcription factor LEF-1. Nature. 382:1996;638-642.
5. Berchuck A., Rodriguez G., Olt G., Whitaker R., Boente M.P., Arrick B.A., Clarke-Pearson D.L., Bast R.C. Regulation of growth of normal ovarian epithelial cells and ovarian cancer cell lines by transforming growth factor-beta. Am. J. Obstet. Gynecol. 166:1992;676-684.
6. Berchuck A., Kohler M.F., Boente M.P., Rodriguez G.C., Whitaker B.S., Bast R.C. Growth regulation and transformation of ovarian epithelium. Cancer. 71:1993;545-551.
7. Birchmeier W., Behrens J. Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasivness. Biochim. Biophys. Acta. 1198:1994;11-26.
8. Birchmeier W., Weidner K.M., Behrens J. Molecular mechanisms leading to loss of differentiation and gain of invasiveness in epithelial cells. J. Cell Sci. Suppl. 17:1993;159-164.
9. Bjersing L., Cajander S. Ovulation and the mechanism of follicular rupture. I. Light microscopic changes in rabbit ovarian follicles prior to induced ovulation. Cell Tissue Res. 149:1974;287-300.
10. Blaustein A. Anatomy and histology of the human ovary. Blaustein A. Pathology of the Female Genital Tract. 1995;741-751 Springer-Verlag, New York, Heidelberg, Berlin.
11. Blaustein A., Lee H. Surface cells of the ovary and pelvic peritoneum: a histochemical and ultrastructure comparison. Gynecol. Oncol. 8:1979;34-43.
12. Brannstrom M., Zackrisson U., Hagstrom H.G., Josefsson B., Hellberg P., Granberg S., Collins W.P., Bourne T. Preovulatory changes of blood flow in different regions of the human follicle. Fertil. Steril. 69:1998;435-442.
13. Darai E., Scoazec J.-Y., Walker-Combrouze F., Mlika-Cabanne N., Feldmann G., Madelenat P., Potet F. Expression of cadherins in benign, borderline, and malignant ovarian epithelial tumors: a clinicopathologic study of 60 cases. Hum. Pathol. 28:1997;922-928.
14. Darai E., Bringuier A.-F., Walker-Combrouze F., Feldmann G., Madelenat P., Scoazec J.-Y. Soluble adhesion molecules in serum and cyst fluid from patients with cystic tumours of the ovary. Hum. Reprod. 13:1998;2831-2835.
15. Davies B.R., Worsley S.D., Ponder B.A.J. Expression of E-cadherin, alfa-catenin, beta-catenin in normal ovarian surface epithelium and epithelial ovarian cancers. Histopathology. 32:1998;69-80.
16. Deng G., Lu Y., Zlotnikov G., Thor A.D., Smith H.S. Loss of heterozygosity in normal tissue adjacent to breast carcinomas. Science. 274:1996;2057-2059.
17. Dorudi S., Sheffield J.P., Poulsom R., Northover J.M., Hart I.R. E-cadherin expression in colorectal cancer. An immunocytochemical and in situ hybridization study. Am. J. Pathol. 142:1993;981-986.
18. Dubeau L. The cell of origin of ovarian epithelial tumors and the ovarian surface epithelium dogma: does the emperor have no clothes? Gynecol. Oncol. 72:1999;437-442.
19. Dyck H.G., Hamilton T.C., Godwin A.K., Lynch H.T., Maines-Bandiera S.L., Auersperg N. Autonomy of the epithelial phenotype in human ovarian surface epithelium: changes with neoplastic progression and with a family history of ovarian cancer. Int. J. Cancer. 69:1996;429-436.
20. Edelman G.M. Surface modulation in cell recognition and cell growth. Science. 192:1976;218-226.
21. Fathalla M.F. Incessant ovulation - a factor in ovarian neoplasia? Lancet. 2:1971;163.
22. Fearon E.R. Tumor suppressor genes. Vogelstein B., Kinzler K.W. The Genetic Basis of Human Cancer. 1998;229-240 McGraw-Hill, New York.
23. Frixen U.H., Behrens J., Sachs M., Eberle G., Voss B., Warda A., Löchner D., Birchmeier W. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J. Cell Biol. 113:1991;173-185.
24. Fujimoto J., Ichigo S., Hirose R., Sakaguchi H., Tamaya T. Expression of E-cadherin and alfa- and beta-catenin mRNAs in ovarian cancers. Cancer Lett. 115:1997;207-212.
25. Fujimoto J., Ichigo S., Hirose R., Skaguchi H., Tamaya T. Suppression of E-cadherin and alfa- and beta-catenin mRNA expression in the metastatic lesions of gynecological cancers. Eur. J. Gynaecol. Oncol. 6:1997;484-487.
26. Gamallo C., Palacios J., Moreno G., Calvo de Mora J., Suarez A., Armas A. Beta-catenin expression pattern in stage I and II ovarian carcinomas: relationship with beta-catenin gene mutations, clinicopathological features, and clinical outcome. Am. J. Pathol. 155:1999;527-536.
27. Geiger B., Ayalon O. Cadherins. Annu. Cell. Biol. 8:1992;307-332.
28. Gillett W.R., Mitchell A., Hurst P.R. A scanning electron microscopic study of the human ovarian surface epithelium: characterization of two cell types. Hum. Reprod. 6:1991;645-650.
29. Guilford P., Hopkins J., Harraway J., Mcleod M., Mcleod N., Harawira P., Taite H., Scoular R., Miller A., Reeve A.E. E-cadherin germline mutations in familial gastric cancer. Nature. 392:1998;402-405.
30. Gumbiner B.M. Cell adhesion: the molecular basis of the tissue architecture and morphogenesis. Cell. 84:1996;345-357.
31. Gumbiner B.M., McCrea P.D. Catenins as mediators of the cytoplasmic functions of cadherins. J. Cell Sci. 17:1993;155-158.
32. Hanby A.M., Chinery R., Poulsom R., Playford R.J., Pignatelli M. Downregulation of E-cadherin in the reparative epithelium of the human gastrointestinal tract. Am. J. Pathol. 148:1996;723-729.
33. Hashimoto M., Niwa O., Nitta Y., Takeichi M., Yokoro K. Unstable expression of E-cadherin adhesion molecules in metastatic ovarian tumor cells. Jpn. J. Cancer Res. 80:1989;459-463.
34. Hermiston M.L., Gordon J.I. In vivo analysis of cadherin function in the mouse intestinal epithelium: essential roles in adhesion, maintenance of differentiation, and regulation of programmed cell death. J. Cell Biol. 129:1995;489-506.
35. Hermiston M.L., Gordon J.I. Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin. Science. 270:1995;1203-1206.
36. Hinck L., Näthke I.S., Papkoff J., Nelson J. Dynamics of cadherin/catenin complex formation: novel protein interactions and pathways of complex assembly. J. Cell Biol. 125:1994;1327-1340.
37. Inoue M., Ogawa H., Miyata M., Shiozaki H., Tanizawa O. Expression of E-cadherin in normal, benign and malignant tissue of female organs. Am. J. Pathol. 98:1991;76-80.
38. Ivarsson K., Sundfeldt K., Brannstrom M., Janson P.-O. Production of steroids by human ovarian surface epithelial cells in culture: possible role of progesterone as growth inhibitor. Gynecol. Oncol. 82:(1):2001;116-121.
39. Ivarsson K., Sundfeldt K., Brannstrom M., Hellberg P., Janson P.-O. Diverse effects of FSH and LH on proliferation of human ovarian surface epithelial cells. Hum. Reprod. 16:(1):2001;18-23.
40. Jindal S.K., Snoey D.M., Lobb D.K., Dorrington J.H. Transforming growth factor alfa localization and role in surface epithelium of normal human ovaries and in ovarian carcinoma cells. Gynecol. Oncol. 53:1994;17-23.
41. Karlan B.Y., Baldwin R.L., Cirisano F.D., Mamula P.W., Jones J., Lasgasse L.D. Secreted ovarian stromal substance inhibits ovarian epithelial cell proliferation. Gynecol. Oncol. 59:1995;67-74.
42. Karlan B.Y., Jones J.L., Greenwald M., Lagasse L.D. Steroid hormone effects on the proliferation of human ovarian surface epithelium in vitro. Am. J. Obstet. Gynecol. 173:1995;97-104.
43. Kinsella A.R., Green B., Lepts G.C., Hill C.L., Bowie G., Taylor B.A. The role of the cell-cell adhesion molecule E-cadherin in large bowel tumor cell invasion metastasis. Br. J. Cancer. 67:1993;804-909.
44. Korinek V., Barker N., Morin J.P., Van Wichen D., De Weger R., Kinzler W.K., Vogelstein B., Clevers H. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science. 275:1997;1784-1787.
45. Kruk P.A., Auersperg N. Human ovarian surface epithelial cells are capable of physically restructuring extracellular matrix. Am. J. Obstet. Gynecol. 167:1992;1437-1443.
46. Lidor Y.J., Xu F.J., Martínez-Maza O., Olt G.J., Marks J.R., Berchuck A., Ramakrishnan S., Berek J.S., Bast R.C. Constitutive production of macrophage colony-stimulating factor and interleukin-6 by human ovarian surface epithelial cells. Exp. Cell Res. 207:1993;332-339.
47. Maines-Bandiera S.L., Auersperg N. Increased E-cadherin expression in ovarian surface epithelium: an early step in metaplasia and dysplasia? Int. J. Gynecol. Pathol. 16:1997;250-255.
48. Mareel M., Vleminckx K., Vermeulen S., Yan G., Bracke M., Van Roy F. Downregulation in vivo of the invasion-suppressor molecule E-cadherin in experimental and clinical cancer. Princess Takamatsu Symp. 24:1994;63-80.
49. Molenaar M., Van De Wetering M., Oosterwegel M., Peterson-Maduro J., Godsave S., Korinek V., Roose J., Destrée O., Clevers H. XTct-3 transcription factor mediates beta-catenin-induced axis formation in Xenopus embryos. Cell. 86:1996;391-399.
50. Morin J.P., Sparks B.A., Korinek V., Barker N., Clevers H., Vogelstein B., Kinzler W.K. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science. 275:1997;1787-1790.
51. Nagafuchi A., Shirayoshi Y., Okazaki K., Yasuda K., Takeichi M. Transformation of cell adhesion properties by exogenously introduced E-cadherin cDNA. Nature. 329:1987;341-343.
52. Nicosia S.V., Saunders B.O., Acevedo-Duncan M.E., Setrakian S., Degregorio R. Biopathology of ovarian mesothelium. Familiare G., Makabe S., Motta P.M. Ultrastructure of the Ovary. 1991;287-310 Kluwer, Germany.
53. Niessen C.M., Gumbiner G.M. Cadherin-mediated cell sorting not determined by binding or adhesion specificity. J. Cell Biol. 156:(2):2002;389-399.
54. Nose A., Nagafuchi A., Takeichi M. Expressed recombinant cadherins mediate cell sorting in model systems. Cell. 54:1988;993-1001.
55. Oka H., Shiozaki H., Kobayashi K., Tahara H., Tamura S., Miyata M., Doki Y., Iihara K., Matsuyoshi N., Hirano S., Et A.L. Immunohistochemical evaluation of E-cadherin adhesion molecule expression in human gastric cancer. Virchows Arch. A: Pathol. Anat. Histopathol. 421:1992;149-156.
56. Ong A., Maines-Bandiera S.L., Roskelley C.D., Auersperg N. An ovarian adenocarcinoma line derived from SV40/E-cadherin-transfected normal human ovarian surface epithelium. Int. J. Cancer. 85:(3):2000;430-437.
57. Peralta Soler A., Knudsen K.A., Jaurand M.C., Johnson K.R., Wheelock M.J., Klein Szanto A.J., Salazar H. The differential expression of N-cadherin and E-cadherin distinguishes pleural mesotheliomas from lung adenocarcinomas. Hum. Pathol. 26:1995;1363-1369.
58. Peralta Soler A., Knudsen K.A., Tecson-Miguel A., Mcbrearty F.X., Han A.C., Salazar H. Expression of E-cadherin and N-cadherin in surface epithelial-stromal tumors of the ovary distinguishes mucinous from serous and endometrioid tumors. Hum. Pathol. 28:1997;734-739.
59. Perl A.K., Wilgenbus P., Dahl U., Semb H., Christofori G. A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature. 392:1998;190-193.
60. Puls L.E., Powell D.E., Depriest P.D., Gallion H.H., Hunter J.E., Kryscio R.J., Van Nagell J.R.J. Transition from benign to malignant epithelium in mutinous and serous ovarian cystadenocarcinoma. Gynecol. Oncol. 47:1992;53-57.
61. Radisavljevic S.V. The pathogenesis of ovarian inclusion cysts and cystomas. Obstet. Gynecol. 49:1976;424-429.
62. Riman T., Persson I., Nilsson S. Hormonal aspects of epithelial ovarian cancer: review of epidemiological evidence. Clin. Endocrinol. 49:1998;695-707.
63. Risinger J.I., Berchuck A., Kohler M.F., Boyd J. Mutations of the E-cadherin gene in human gynecologic cancers. Nat. Genet. 7:1994;98-102.
64. Ross J.F., Rosario D.A., Figge L.H., Sheehan C., Fisher H.A., Bui H.X. E-cadherin expression in papillary transitional cell carcinoma of the urinary bladder. Hum. Pathol. 26:1995;940-944.
65. Rubinfeld B., Albert I., Porfiri E., Fiol C., Munemitsu S., Polakis P. Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly. Science. 272:1996;1023-1025.
66. Rubinfeld B., Robbins P., El-Gamil M., Albert I., Porfiri E., Polakis P. Stabilization of beta-catenin by genetic defects in melanoma cell lines. Science. 275:1997;1790-1792.
67. Sakuragi N., Nishiya M., Ikeda K., Ohkouch T., Furth E.E., Hareyama H., Satoh C., Fujimoto S. Decreased E-cadherin expression in endometrial carcinoma is associated with tumor dedifferentiation and deep myometrial invasion. Gynecol. Oncol. 53:1994;183-189.
68. Schofield K., D'Aquila T., Rimm D.L. The cell adhesion molecule, E-cadherin, distinguishes mesothelial cells from carcinoma cells in fluids. Cancer. 81:1997;293-298.
69. Scubitz A.P. Adhesion molecules. Cancer Treat. Res. 107:2002;305-329.
70. Scully R.E. Pathology of ovarian cancer precursors. J. Cell Biochem. Suppl. 23:1995;208-218.
71. Shimoyama Y., Hirohashi S., Hirano S., Noguchsi M., Shimosato Y., Takeichi M., Osahiko. A. Cadherin cell-adhesion molecules in human epithelial tissue and carcinomas. Cancer Res. 49:1989;2128-2133.
72. Shiozaki H., Oka H., Inoue M., Tamura S., Monden M. E-cadherin mediated adhesion system in cancer cells. Cancer. 77:1996;1605-1613.
73. Shore E.M., Nelson W.J. Biosynthesis of the cell adhesion molecule uvomorulin (E-cadherin) in Madin-Darby canine kidney epithelial cells. J. Biol. Chem. 266:1991;19672-19680.
74. Sundfeldt K., Piontkewitz Y., Ivarsson K., Nilsson O., Hellberg P., Brannstrom M., Janson P.-O., Enerback S., Hedin L. E-cadherin expression in human epithelial ovarian cancer and normal ovary. Int. J. Cancer. 74:(3):1997;275-280.
75. Sundfeldt K., Ivarsson K., Rask K., Haeger M., Hedin L., Brannstrom M. Higher levels of soluble E-cadherin in cyst fluid from malignant ovarian tumours than in benign cysts. Anticancer Res. 21:(1A):2001;65-70.
76. Takeichi M. Cadherin cell adhesion receptors as morphogenetic regulator. Science. 251:1991;1451-1455.
77. Trolice M.P., Pappalardo A., Peluso J. Basic fibroblast growth factor and N-cadherin maintain rat granulosa cell and ovarian surface epithelial cell viability by stimulating the tyrosine phosphorylation of the fibroblast growth factor receptors. Endocrinology. 138:1997;107-113.
78. Umbas R., Schalken J.A., Aalders T.W., Carter B.S., Karthaus F.M., Schaafsma H.E., Debruyne F.M.J., Isaacs W.B. Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer. Cancer Res. 52:1992;5104-5109.
79. Van Roy F., Mareel M. Tumour invasion: effects of cell adhesion and motility. Trends Cell Biol. 2:1992;163-169.
80. Vanderburg C.R., Hay E.D. E-cadherin transforms embryonic corneal fibroblasts to stratified epithelium with desmosomes. Acta Anat. (Basel). 157:1996;87-104.
81. Veatch A.L., Carson L.F., Ramakrishnan S. Differential expression of the cell-cell adhesion molecule E-cadherin in ascites and solid human ovarian tumor cells. Int. J. Cancer. 58:1994;393-399.
82. Vigne J.-L., Halburnt L.L., Skinner M.K. Characterization of bovine ovarian surface epithelium and stromal cells: identification of secreted proteins. Biol. Reprod. 51:1994;1213-1221.
83. Vleminckx K., Vakaet J.L., Mareel M., Fiers W., Van Roy F. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion supressor role. Cell. 66:1991;107-119.
84. Wheelock M.J., Buck C.A., Bechtol K.B., Damsky C.H. Soluble 80-kd fragment of cell-CAM 120/80 disrupts cell-cell adhesion. J. Cell Biochem. 34:1987;187-202.
85. Wong A.S.T., Maines B., Rosen B., Wheelock M.J., Johnson K.R., Leung P.C.K., Roskelley C.D., Auersperg N. Constitutive and conditional cadherin expression in cultured human ovarian surface epithelium: influence of family history of ovarian cancer. Int. J. Cancer. 81:1999;180-188.
86. Wright K., Wilson P., Morland S., Campbell I., Walsh M., Hurst T., Ward B., Cummings M., Chenevix-Trench G. Beta-catenin mutation and expression analysis in ovarian cancer: exon 3 mutations and nuclear translocation in 16% of endometrioid tumours. Int. J. Cancer. 82:1999;625-629.
87. Zhu A.J., Watt F.M. Expression of a dominant negative cadherin mutant inhibits proliferation and stimulates terminal differentiation of human epidermal keratinocytes. J. Cell Sci. 109:1996;3013-3023.
88. Ziltener H.J., Maines-Bandiera S., Schrader J.W., Auersperg N. Secretion of bioactive interleukin-1, interleukin-6, and colony-stimulating factors by human ovarian surface epithelium. Biol. Reprod. 49:1993;635-641.